Skip to content
★ Sign in to follow
DC

Donal Carroll

FSD Pharma Inc.
Total declarations
39
Company
1
▲ Purchases (33 ops.)
€162k
▼ Sales (2 ops.)
€385k

Latest filing published 21 May 2024 for FSD Pharma Inc., €210k.

Filing timeline

BuySale
Donal Carroll

Insider track record

Disclosed buys
33
Disclosed sells
2
Signal history

Donal Carroll: trading record in brief

Donal Carroll is a declared insider of FSD Pharma Inc., with filings sourced from SEDI. We count 39 filings; the first trade dates from 20 September 2018 and the latest from 21 May 2024.

The open-market side counts 33 purchases for €162k alongside 2 sales for €385k. Sales outweigh purchases by €223k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 option exercise.

In size, the median ticket on the buying side is €4,580. None of the 26 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The record was last updated on 21 May 2024 with a transaction (€210k) in FSD Pharma Inc. The latest purchase dates back some time: it was published 1,195 days ago, on 1 August 2023. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Donal Carroll

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations39 total
  • ●
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    311,446 CAD14SEDI
    973,268 shares@ CA$0.3228.5% of flowSubordinate Voting Shares Class BTSXSEDI:4317372
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    2,920 CAD15SEDI
    2,000 shares@ CA$1.460.3% of flowSubordinate Voting Shares Class BTSXSEDI:4164125
    Canonical exit: 26 Oct 2023 (T+90)
  • ◇
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    0SEDI
    704,801 sharesSubordinate Voting Shares Class BTSXSEDI:4065795
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    2,052 CAD11SEDI
    1,900 shares@ CA$1.080.3% of flowSubordinate Voting Shares Class BTSXSEDI:4056306
    Canonical exit: 4 Apr 2023 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    129 CAD11SEDI
    123 shares@ CA$1.050.0% of flowSubordinate Voting Shares Class BTSXSEDI:4056303
    Canonical exit: 4 Apr 2023 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    1,180 CAD0SEDI
    1,000 shares@ CA$1.18Subordinate Voting Shares Class BTSXSEDI:4007533
    Canonical exit: 25 Dec 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    1,150 CAD0SEDI
    1,000 shares@ CA$1.15Subordinate Voting Shares Class BTSXSEDI:4007534
    Canonical exit: 25 Dec 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    4,200 CAD0SEDI
    3,500 shares@ CA$1.20Subordinate Voting Shares Class BTSXSEDI:4007530
    Canonical exit: 25 Dec 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    1,170 CAD0SEDI
    1,000 shares@ CA$1.17Subordinate Voting Shares Class BTSXSEDI:4007536
    Canonical exit: 25 Dec 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    1,280 CAD0SEDI
    1,000 shares@ CA$1.28Subordinate Voting Shares Class BTSXSEDI:4007539
    Canonical exit: 26 Dec 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    6,467 CAD0SEDI
    5,000 shares@ CA$1.2934Subordinate Voting Shares Class BTSXSEDI:4007537
    Canonical exit: 26 Dec 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    4,162 CAD17SEDI
    4,162 shares@ CA$1.000.3% of flowSubordinate Voting Shares Class BTSXSEDI:3988511
    Canonical exit: 10 Nov 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    2,962 CAD0SEDI
    3,000 shares@ CA$0.9872Subordinate Voting Shares Class BTSXSEDI:3978743
    Canonical exit: 13 Oct 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    2,045 CAD17SEDI
    2,045 shares@ CA$1.000.2% of flowSubordinate Voting Shares Class BTSXSEDI:3958651
    Canonical exit: 5 Sept 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    3,380 CAD17SEDI
    3,380 shares@ CA$1.000.3% of flowSubordinate Voting Shares Class BTSXSEDI:3958683
    Canonical exit: 6 Sept 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    12,419 CAD17SEDI
    10,000 shares@ CA$1.24191.2% of flowSubordinate Voting Shares Class BTSXSEDI:3957768
    Canonical exit: 1 Sept 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    635 CAD17SEDI
    500 shares@ CA$1.270.1% of flowSubordinate Voting Shares Class BTSXSEDI:3950647
    Canonical exit: 24 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    13,000 CAD17SEDI
    10,000 shares@ CA$1.301.3% of flowSubordinate Voting Shares Class BTSXSEDI:3950650
    Canonical exit: 24 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    12,600 CAD17SEDI
    10,000 shares@ CA$1.261.2% of flowSubordinate Voting Shares Class BTSXSEDI:3950644
    Canonical exit: 24 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    12,160 CAD17SEDI
    9,500 shares@ CA$1.281.2% of flowSubordinate Voting Shares Class BTSXSEDI:3950648
    Canonical exit: 24 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    6,065 CAD17SEDI
    5,000 shares@ CA$1.2130.6% of flowSubordinate Voting Shares Class BTSXSEDI:3949784
    Canonical exit: 17 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    3,842 CAD17SEDI
    3,400 shares@ CA$1.130.4% of flowSubordinate Voting Shares Class BTSXSEDI:3945825
    Canonical exit: 11 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    6,400 CAD17SEDI
    5,000 shares@ CA$1.280.6% of flowSubordinate Voting Shares Class BTSXSEDI:3938940
    Canonical exit: 1 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    12,600 CAD17SEDI
    10,000 shares@ CA$1.261.3% of flowSubordinate Voting Shares Class BTSXSEDI:3938942
    Canonical exit: 1 Aug 2022 (T+90)
  • ▲
    4 - Director of IssuerExecutivesFSD Pharma Inc.
    6,350 CAD17SEDI
    5,000 shares@ CA$1.270.6% of flowSubordinate Voting Shares Class BTSXSEDI:3938941
    Canonical exit: 1 Aug 2022 (T+90)

25 of 39 declarations